Our Products

Rotary Evaporator

Laboratory equipment

Jacketed Reactor

Contact Us

4 - Pharmaceutical Technology

4 - Pharmaceutical Technology

The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Pharmaceutical Technology is using cookies We use them to give you the best experience.

PHARMACEUTICAL & BIOTECHNOLOGY

PHARMACEUTICAL & BIOTECHNOLOGY

2018-9-12 · A total of approximately 4,500 L bioreactor capacity will be installed, including two 2,000 L traditional fed-batch and one 500 L perfusion-based continuous processing units. The manufacturing facility, supported by the Singapore Economic Development Board (EDB), will be capable of handling both clinical and small volume commercial production.

New Horizons in Biotechnology | Request PDF

New Horizons in Biotechnology | Request PDF

That research was the basis for scale-up processes in a pilot plant with 100L, 1000L, 10,000L bioreactors for repeated batch and continuous processes employing kefir granules and DC materials .

Cell Technology for Cell Products (ESACT Proceedings .

Cell Technology for Cell Products (ESACT Proceedings .

The Use of a Mobile Robot for Complete Sample Management in a Cell Culture Pilot Plant 543–547 M. Wojtczyk, R. Heidemann, K. Joeris, C. Zhang, M. Burnett, A. Knoll, and K. Konstantinov Closed Loop Control of Perfusion Systems in High-density Cell Culture A. Bock and U. Reichl Optimization of Culture Medium with the Use of Protein Hydrolysates .

4 - Pharmaceutical Technology

4 - Pharmaceutical Technology

The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Pharmaceutical Technology is using cookies We use them to give you the best experience.

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler provides intermediate reactor volume for commercial production and clinical trials. The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Rentschler Biotechnologie was the first company to get approval for an interferon drug.

New Horizons in Biotechnology | Request PDF

New Horizons in Biotechnology | Request PDF

That research was the basis for scale-up processes in a pilot plant with 100L, 1000L, 10,000L bioreactors for repeated batch and continuous processes employing kefir granules and DC materials .

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler provides intermediate reactor volume for commercial production and clinical trials. The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Rentschler Biotechnologie was the first company to get approval for an interferon drug.

Drivers, Opportunities, and Limits of Continuous .

Drivers, Opportunities, and Limits of Continuous .

2020-8-13 · For the ICB mode, several 500-L disposable reactors are used; for fed-batch antibody production, two 10,000-L stainless steel bioreactors, and for nonantibodies a six-pack of 2,000-L reactors are used (18). Comparing fed-batch, spin-filter perfusion, and ATF perfusion cultivation revealed a 20% CoGS savings benefit over traditional fed-batch .

PHARMACEUTICAL & BIOTECHNOLOGY

PHARMACEUTICAL & BIOTECHNOLOGY

2016-9-29 · Rentschler Biotechnologie has opened a facility at its site in Laupheim, Germany and plans to create 200 new jobs. The plant – which cost €24m ( 26m) - houses two 3,000 liter stainless steel bioreactors linked to a protein purification system. . Compared to traditional batch-fed biomanufacturing processes, perfusion allows the continuous .

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler provides intermediate reactor volume for commercial production and clinical trials. The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Rentschler Biotechnologie was the first company to get approval for an interferon drug.

PHARMACEUTICAL & BIOTECHNOLOGY

PHARMACEUTICAL & BIOTECHNOLOGY

2016-9-29 · Rentschler Biotechnologie has opened a facility at its site in Laupheim, Germany and plans to create 200 new jobs. The plant – which cost €24m ( 26m) - houses two 3,000 liter stainless steel bioreactors linked to a protein purification system. . Compared to traditional batch-fed biomanufacturing processes, perfusion allows the continuous .

Drivers, Opportunities, and Limits of Continuous .

Drivers, Opportunities, and Limits of Continuous .

2020-8-13 · For the ICB mode, several 500-L disposable reactors are used; for fed-batch antibody production, two 10,000-L stainless steel bioreactors, and for nonantibodies a six-pack of 2,000-L reactors are used (18). Comparing fed-batch, spin-filter perfusion, and ATF perfusion cultivation revealed a 20% CoGS savings benefit over traditional fed-batch .

Single Use Technology and Equipment - ScienceDirect

Single Use Technology and Equipment - ScienceDirect

2018-1-1 · The concern that single use technology would not meet the capacity demands of the industry has been mitigated by the increase in cell culture titers over the last decade [].Table 29.1 shows the annual monoclonal antibody production capacity of a single use facility (in kilograms of purified bulk drug substance (BDS)/year) as a function of cell productivity (product titer in the bioreactor) and .

Cell Technology for Cell Products (ESACT Proceedings .

Cell Technology for Cell Products (ESACT Proceedings .

The Use of a Mobile Robot for Complete Sample Management in a Cell Culture Pilot Plant 543–547 M. Wojtczyk, R. Heidemann, K. Joeris, C. Zhang, M. Burnett, A. Knoll, and K. Konstantinov Closed Loop Control of Perfusion Systems in High-density Cell Culture A. Bock and U. Reichl Optimization of Culture Medium with the Use of Protein Hydrolysates .

Cell Technology for Cell Products (ESACT Proceedings .

Cell Technology for Cell Products (ESACT Proceedings .

The Use of a Mobile Robot for Complete Sample Management in a Cell Culture Pilot Plant 543–547 M. Wojtczyk, R. Heidemann, K. Joeris, C. Zhang, M. Burnett, A. Knoll, and K. Konstantinov Closed Loop Control of Perfusion Systems in High-density Cell Culture A. Bock and U. Reichl Optimization of Culture Medium with the Use of Protein Hydrolysates .

German biomanufacturing guide vc - LinkedIn SlideShare

German biomanufacturing guide vc - LinkedIn SlideShare

Rentschler Biotechnologie has nine GMP suites with volumes of 30, 50, 250, 500, 1,000 and 2,500 liters, allowing the production of material for clinical trials (phase I to III) and for market supply. Rentschler also provides regulatory advice, protein analytics, quality control, and the sterile filling of .

Drivers, Opportunities, and Limits of Continuous .

Drivers, Opportunities, and Limits of Continuous .

2020-8-13 · For the ICB mode, several 500-L disposable reactors are used; for fed-batch antibody production, two 10,000-L stainless steel bioreactors, and for nonantibodies a six-pack of 2,000-L reactors are used (18). Comparing fed-batch, spin-filter perfusion, and ATF perfusion cultivation revealed a 20% CoGS savings benefit over traditional fed-batch .

PHARMACEUTICAL & BIOTECHNOLOGY

PHARMACEUTICAL & BIOTECHNOLOGY

2016-9-29 · Rentschler Biotechnologie has opened a facility at its site in Laupheim, Germany and plans to create 200 new jobs. The plant – which cost €24m ( 26m) - houses two 3,000 liter stainless steel bioreactors linked to a protein purification system. . Compared to traditional batch-fed biomanufacturing processes, perfusion allows the continuous .

Drivers, Opportunities, and Limits of Continuous .

Drivers, Opportunities, and Limits of Continuous .

2020-8-13 · For the ICB mode, several 500-L disposable reactors are used; for fed-batch antibody production, two 10,000-L stainless steel bioreactors, and for nonantibodies a six-pack of 2,000-L reactors are used (18). Comparing fed-batch, spin-filter perfusion, and ATF perfusion cultivation revealed a 20% CoGS savings benefit over traditional fed-batch .

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler provides intermediate reactor volume for commercial production and clinical trials. The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Rentschler Biotechnologie was the first company to get approval for an interferon drug.

PHARMACEUTICAL & BIOTECHNOLOGY

PHARMACEUTICAL & BIOTECHNOLOGY

2018-9-12 · A total of approximately 4,500 L bioreactor capacity will be installed, including two 2,000 L traditional fed-batch and one 500 L perfusion-based continuous processing units. The manufacturing facility, supported by the Singapore Economic Development Board (EDB), will be capable of handling both clinical and small volume commercial production.

PHARMACEUTICAL & BIOTECHNOLOGY

PHARMACEUTICAL & BIOTECHNOLOGY

2018-9-12 · A total of approximately 4,500 L bioreactor capacity will be installed, including two 2,000 L traditional fed-batch and one 500 L perfusion-based continuous processing units. The manufacturing facility, supported by the Singapore Economic Development Board (EDB), will be capable of handling both clinical and small volume commercial production.

PHARMACEUTICAL & BIOTECHNOLOGY

PHARMACEUTICAL & BIOTECHNOLOGY

2016-9-29 · Rentschler Biotechnologie has opened a facility at its site in Laupheim, Germany and plans to create 200 new jobs. The plant – which cost €24m ( 26m) - houses two 3,000 liter stainless steel bioreactors linked to a protein purification system. . Compared to traditional batch-fed biomanufacturing processes, perfusion allows the continuous .

Tracking CMO Investments in Biologics Manufacturing

Tracking CMO Investments in Biologics Manufacturing

2020-5-10 · The new facility is to be completed by January 2017 and will house fourteen 2000-L disposable bioreactors for fed-batch cell culture and two 1000-L bioreactors for perfusion runs. The facility will also be built to run advanced continuous or semi-continuous manufacturing processes in addition to traditional fed-batch and perfusion modes.

Diatomaceous Earth Filtration: Innovative Single-Use .

Diatomaceous Earth Filtration: Innovative Single-Use .

2020-8-15 · At Rentschler Biotechnologie, we performed tests at pilot production scale to evaluate the applicability of DBF technology for manufacturing purposes . In total, 1,000 L of a high–cell-density (17.6 × 10 6 cells/mL, 95% viability) Chinese hamster ovary (CHO) cell fed-batch culture were available for the depth-filtration and body-feed .

4 - Pharmaceutical Technology

4 - Pharmaceutical Technology

The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Pharmaceutical Technology is using cookies We use them to give you the best experience.

4 - Pharmaceutical Technology

4 - Pharmaceutical Technology

The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Pharmaceutical Technology is using cookies We use them to give you the best experience.

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler Biotechnologie, New Manufacturing Capacity .

Rentschler provides intermediate reactor volume for commercial production and clinical trials. The reactors installed in the Laupheim facility can be used with batch, fed-batch, or perfusion processes. Rentschler Biotechnologie was the first company to get approval for an interferon drug.

Drivers, Opportunities, and Limits of Continuous .

Drivers, Opportunities, and Limits of Continuous .

2020-8-13 · For the ICB mode, several 500-L disposable reactors are used; for fed-batch antibody production, two 10,000-L stainless steel bioreactors, and for nonantibodies a six-pack of 2,000-L reactors are used (18). Comparing fed-batch, spin-filter perfusion, and ATF perfusion cultivation revealed a 20% CoGS savings benefit over traditional fed-batch .